Original Publication Date: 1 May, 2016
Publication / Source: Future Oncology
Authors: Christina Vorvis, Marina Koutsioumpa & Dimitrios Iliopoulos
Pancreatic cancer is a devastating malignancy that ranks as the fourth leading cause of cancer-related deaths worldwide. Dismal prognosis is mainly attributable to limited knowledge of the molecular pathogenesis of the disease. miRNAs have been found to be deregulated in pancreatic cancer, affecting several steps of initiation and aggressiveness of the disease by regulating important signaling pathways, such as the KRAS and Notch pathways.